AI assistant
CORE LITHIUM LTD — Director's Dealing 2018
Jul 3, 2018
64737_rns_2018-07-03_5fb50c5e-e0ea-4323-8521-2e34937963df.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
| Name of entity | Core Exploration Limited |
|---|---|
| ABN | 80 146 287 809 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | StephenBIGGINS |
|---|---|
| Date of last notice | 21 June 2018 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Indirect | |
|---|---|---|
| Nature of indirect interest | 1. Mr Biggins is a director of | and has |
| (including registered holder) | abeneficialinterest | inthe |
| Note: Provide details of the circumstances giving rise to the relevantinterest. | registeredholder | Nowak |
| Investments Pty Ltd ATF The | ||
| NowakSuperannuation | Fund | |
| (Nowak) | ||
| 2. Mr Biggins is a director of | and has | |
| abeneficialinterest | inthe | |
| registered holder Genex Resources | ||
| Pty Ltd ATF Biggins Resources | ||
| Family Trust (Genex) | ||
| Date of change | 3 July 2018 |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held prior to change | 5,979,680 Shares held by Nowak | |
|---|---|---|
| 2,216,667 Shares held by Genex | ||
| 6,500,000 unlisted Performance Rights | ||
| subject to vesting criteria, expiring | at | |
| various times to 30 September 2020 held | ||
| by Genex | ||
| Class | Shares - Fully paid ordinary shares. | |
| PerformanceRights–subject | to | |
| satisfaction of performance conditions. | ||
| Number acquired | None | |
| Number disposed | 1,500,000 Performance Rights | |
| Value/Consideration | Nil | |
| Note: If consideration is non-cash, provide details and estimated | ||
| valuation | ||
| No. of securities held after change | 5,979,680 Shares held by Nowak | |
| 2,216,667 Shares held by Genex | ||
| 5,000,000 unlisted Performance Rights | ||
| subject to vesting criteria, expiring | at | |
| various times to 30 September 2020 held | ||
| by Genex | ||
| Nature of change | Lapse of 1,500,000 Performance Rights | – |
| Example: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participation in | performance conditions not met. | |
| buy-back |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | Not applicable |
|---|---|
| Nature of interest | |
| Name of registered holder | |
| (if issued securities) | |
| Date of change | |
| No. and class of securities to which | |
| interest related prior to change | |
| Note: Details are only required for a contract in | |
| relation to which the interest has changed | |
| Interest acquired | |
| Interest disposed | |
| Value/Consideration | |
| Note: If consideration is non-cash, provide details | |
| and an estimated valuation | |
| Interest after change |
Part 3 –[+] Closed period
| Part 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contracts detailed | Not applicable |
| above traded during a+closed period where prior written | |
| clearance was required? | |
| If so, was prior written clearance provided to allow the trade | |
| to proceed during this period? | |
| If prior written clearance was provided, on what date was this | |
| provided? |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3